Integrative metabolome and transcriptome analyses provide insights into PHGDH in colon cancer organoids
Open Access
- 28 January 2025
- journal article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 45 (1) , 1-12
Abstract
As a rate-limiting enzyme in the endogenous serine de novo synthesis pathway, 3-Phosphoglycerate dehydrogenase (PHGDH) has been widely concerned about its role in a variety of tumors including colon cancer and the development of inhibitors. In our previous study, we studied PHGDH in colon cancer cell lines. However, with the development of personalized therapy, we realized that in scientific research, two-dimensional cell lines lost a lot of original characteristic information during long-term culture, and the results obtained may not be enough to support the conclusion. Patient-derived tumor organoids maintain genomic stability and make up for information missing from cell lines due to monoclonal growth. Therefore, in our study, a colon cancer organoid with high PHGDH expression was selected and analyzed for transcriptomic and metabolomic changes through targeted inhibition of PHGDH. The results showed that inhibition of PHGDH significantly inhibited the proliferation of colon cancer organoids. The transcriptome, metabolome, and combined omics analysis showed that the changes in colon cancer organoids after inhibition of PHGDH were mainly involved in PRSS1 and PRSS56, steroid hormone biosynthesis, phenylalanine metabolism, ascorbate and aldarate metabolism, and tyrosine metabolism. In our study, the role of PHGDH in serine metabolism in colon cancer organoids was clarified by multi-omics analysis to provide new knowledge for an in-depth understanding of serine metabolism and PHGDH function in colon cancer.Keywords
Funding Information
- MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Basic Public Welfare Research Program of Zhejiang Province (LTGY23H160025)
- Chinese Medicine Research Program of Zhejiang Province (2024ZL1183)
- Jinhua Science and Technology Bureau (2021-3-035)
- Jinhua Science and Technology Bureau (2021-3-039)
- Jinhua Science and Technology Bureau (2023-3-111)
- Research project of Jinhua Hospital affiliated of Zhejiang University (JY2022-6-04)
- Research project of Jinhua Hospital affiliated of Zhejiang University (JY2020-2-04)
- Jinhua Science and Technology Bureau (2021-4-020)
This publication has 43 references indexed in Scilit:
- Preclinical efficacy of CBR-5884 against epithelial ovarian cancer cells by targeting the serine synthesis pathwayDiscover Oncology, 2024
- Colorectal cancer tissue-originated spheroids reveal tumor intrinsic signaling pathways and mimic patient clinical chemotherapeutic response as a rapid and valid modelBiomedicine & Pharmacotherapy, 2023
- What is cancer metabolism?Cell, 2023
- Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancerCancer Letters, 2021
- Targeting GLS1 to cancer therapy through glutamine metabolismClinical and Translational Oncology, 2021
- Harnessing the Co-vulnerabilities of Amino Acid-Restricted CancersCell Metabolism, 2021
- Trypsin‐Instructed Self‐Assembly on Endoplasmic Reticulum for Selectively Inhibiting Cancer CellsAdvanced Healthcare Materials, 2020
- Serine Availability Influences Mitochondrial Dynamics and Function through Lipid MetabolismCell Reports, 2018
- PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor PrognosisCell Reports, 2017
- Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1Journal of Neuro-Oncology, 2012